Claritev Corporation
CTEVNYSEHealthcare● Active
$27.07
+$1.23(+4.76%)
Market Cap$461483648
P/E Ratio—
52W High$74.07
52W Low$11.5
Claritev Corporation（CTEV）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CTEV · 截至 2026-06-10
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.28B) | ($1.65B) | ($0.09B) | ($0.57B) | $0.10B |
| Depreciation & Amort. | $0.45B | $0.44B | $0.43B | $0.42B | $0.42B |
| Stock-Based Comp. | $0.03B | $0.03B | $0.02B | $0.02B | $0.02B |
| Change in Working Capital | ($0.03B) | ($0.01B) | ($0.02B) | $0.06B | ($0.05B) |
| Net Cash from Operations | $0.12B | $0.11B | $0.17B | $0.37B | $0.40B |
| Investing Activities | |||||
| Capital Expenditure | ($0.13B) | ($0.12B) | ($0.11B) | ($0.09B) | ($0.08B) |
| Purchases of Investments | $0.00B | $0.00B | $0.00B | ($0.01B) | $0.00B |
| Sales of Investments | $0.02B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Cash from Investing | ($0.12B) | ($0.12B) | ($0.25B) | ($0.10B) | ($0.23B) |
| Financing Activities | |||||
| Common Stock Repurchased | $0.00B | ($0.01B) | ($0.02B) | ($0.10B) | ($0.10B) |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | ($0.03B) | ($0.17B) | ($0.01B) | ($0.01B) |
| Net Cash from Financing | $0.00B | ($0.04B) | ($0.18B) | ($0.12B) | ($0.11B) |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.01B) | ($0.01B) | $0.06B | $0.28B | $0.32B |
| FCF Margin %(computed) | -1.27% | -1.13% | 6.54% | 26.18% | 28.64% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Claritev Corporation
关于Claritev Corporation（CTEV）现金流量表
Claritev Corporation 2025财年经营活动现金流$0.12B，自由现金流($0.01B)（FCF利润率-1.27%），资本支出($0.13B)。
常见问题
CTEV · 4 问Claritev Corporation 2025财年自由现金流($0.01B)，同比down16.8%。
CTEV free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10